ストックスクリーナーアプリを入手
11.28
6.21%
0.66
プレマーケット:
11.28
Immunic Inc (IMUX) 最新ニュース
LifeSci Capital Initiates Immunic(IMUX.US) With Buy Rating, Announces Target Price $56 - Moomoo
[EFFECT] IMMUNIC, INC. SEC Filing - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Immunic to Participate in Investor and Medical Conferences in May - Sahm
Who's Buying or Selling Immunic Inc (HAM:10V) Stock Today? - GuruFocus
Immunic Inc (HAM:10V) Valuation - GuruFocus
Immunic Inc (HAM:10V) Dividend - GuruFocus
Immunic Inc (HAM:10V) Stock Price & 30 Year Financial Data - GuruFocus
Immunic Inc (HAM:10V) Competitors 2026 - GuruFocus
Immunic Inc (HAM:10V)Valuation Measures & Financial Statistics - GuruFocus
Immunic Inc Stock Baskets | HAM:10V - GuruFocus
Immunic Inc (HAM:10V) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Immunic Inc Stock Operating Data - GuruFocus
Immunic Inc (HAM:10V) Stock News, Headlines & Updates - GuruFocus
Immunic Inc (HAM:10V) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Immunic Inc (HAM:10V) Stock Earnings Transcripts - GuruFocus
Immunic (NASDAQ: IMUX) registers 45.8M shares after 1-for-10 reverse split - Stock Titan
Q3 2024 Immunic Inc Earnings Call Transcript - GuruFocus
Immunic (IMUX) price target increased by 920.41% to 54.64 - MSN
Immunic Inc (STU:10V) Stock Price & 30 Year Financial Data - GuruFocus
Immunic Inc (STU:10V) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Immunic Inc (STU:10V) Stock Earnings Transcripts - GuruFocus
H.C. Wainwright Maintains Immunic(IMUX.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
IMUX Maintained by HC Wainwright & Co. -- Price Target Raised to $5.00 - GuruFocus
H.C. Wainwright raises Immunic stock price target to $22 on MS drug prospects By Investing.com - Investing.com India
H.C. Wainwright raises Immunic stock price target to $22 on MS drug prospects - Investing.com UK
Immunic (IMUX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Immunic Is Maintained at Buy by HC Wainwright & Co. - Moomoo
Immunic to present MS data, meet investors at May conferences - Proactive financial news
IMUX Forecast, Price Target & Analyst Ratings | IMMUNIC INC (NASDAQ:IMUX) - ChartMill
Immunic, Inc. Common Stock (IMUX) Stock Price Today & Analysis - Gotrade
Debt to equity ratio of Immunic, Inc. – MUN:10V - TradingView
Total liabilities & shareholders' equities of Immunic, Inc. – MUN:10V - TradingView
Current ratio of Immunic, Inc. – MUN:10V - TradingView
Diluted earnings per share (diluted EPS) of Immunic, Inc. – MUN:10V - TradingView
Debt to equity ratio of Immunic, Inc. – LSX:A428WY - TradingView
Pretax income of Immunic, Inc. – MUN:10V - TradingView
Net income of Immunic, Inc. – MUN:10V - TradingView
Debt to equity ratio of Immunic, Inc. – LS:A428WY - TradingView
Total debt per share of Immunic, Inc. – MUN:10V - TradingView
After tax other income/expense of Immunic, Inc. – LS:A428WY - TradingView
Immunic (IMUX) awards CMO 300,000 stock options at $8.80 - Stock Titan
Immunic (IMUX) Chief Medical Officer Michael Panzara files initial Form 3 insider report - Stock Titan
Enterprise value to EBITDA ratio of Immunic, Inc. – TRADEGATE:10V - TradingView
Long term debt to total assets ratio of Immunic, Inc. – TRADEGATE:10V - TradingView
Immunic, Inc. Cash Flow – FWB:10V - TradingView
Asset turnover of Immunic, Inc. – FWB:10V - TradingView
Total liabilities & shareholders' equities of Immunic, Inc. – FWB:10V - TradingView
EBIT per share of Immunic, Inc. – GETTEX:10V - TradingView
Taxes of Immunic, Inc. – GETTEX:10V - TradingView
Current ratio of Immunic, Inc. – GETTEX:10V - TradingView
Total debt of Immunic, Inc. – GETTEX:10V - TradingView
Cash from financing activities of Immunic, Inc. – GETTEX:10V - TradingView
Gross profit of Immunic, Inc. – GETTEX:10V - TradingView
Net income of Immunic, Inc. – GETTEX:10V - TradingView
Tangible book value per share of Immunic, Inc. – GETTEX:10V - TradingView
EBITDA per share of Immunic, Inc. – GETTEX:10V - TradingView
Total liabilities & shareholders' equities of Immunic, Inc. – GETTEX:10V - TradingView
Cash from operating activities of Immunic, Inc. – GETTEX:10V - TradingView
Operating cash flow per share of Immunic, Inc. – GETTEX:10V - TradingView
Total assets of Immunic, Inc. – FWB:10V - TradingView
Price to cash flow ratio of Immunic, Inc. – GETTEX:10V - TradingView
Book value per share of Immunic, Inc. – GETTEX:10V - TradingView
Free cash flow of Immunic, Inc. – FWB:10V - TradingView
Net debt of Immunic, Inc. – FWB:10V - TradingView
Free cash flow of Immunic, Inc. – GETTEX:10V - TradingView
Cash from investing activities of Immunic, Inc. – GETTEX:10V - TradingView
Enterprise value to EBITDA ratio of Immunic, Inc. – GETTEX:10V - TradingView
Immunic, Inc. Earnings and Revenue – FWB:10V - TradingView
Return on equity % of Immunic, Inc. – GETTEX:10V - TradingView
Preferred dividends of Immunic, Inc. – GETTEX:10V - TradingView
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):